::: {.question-block}

<form onsubmit="event.preventDefault(); checkAnswer('module4_mcq_q78')" data-correct-answer="A">
  <strong style="display: block;">Consider a tech startup with little operating history. Its beta is estimated using comparable firms. What is the main limitation of this approach?</strong>
<label><input type="radio" name="module4_mcq_q78" value="A"> A. Comparable firms may operate in different industries or have different leverage, leading to biased beta estimates.</label><br>
<label><input type="radio" name="module4_mcq_q78" value="B"> B. Betas cannot be estimated for startups.</label><br>
<label><input type="radio" name="module4_mcq_q78" value="C"> C. CAPM does not apply to young firms.</label><br>
<label><input type="radio" name="module4_mcq_q78" value="D"> D. Comparable betas must always be higher than startup betas.</label><br>
<label><input type="radio" name="module4_mcq_q78" value="E"> E. The method is never used in practice.</label><br>
</form>

<div id="feedback-module4_mcq_q78" class="feedback" data-status="" style="display:none;">
✅ Correct: A. Comparable firm betas must be carefully chosen. Industry, leverage, and business model differences can bias the startup’s estimated beta.
</div>

:::
